Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Topline phase II data on GKT-137831 support development in fibrotic diseases

Sep. 9, 2015

Cytori stem cell therapy ECCS-50 enters phase III trial in male urinary incontinence

Sep. 8, 2015

Sanofi terminates option to license Ardelyx's RDX-002 program

Sep. 4, 2015

CSIR scientists describe PDE5A inhibitors

Aug. 21, 2015

FDA approves Procysbi for children aged 2-6 years with nephropathic cystinosis

Aug. 18, 2015

First patients randomized in phase IIa trial of SER-150 in diabetic nephropathy

Aug. 17, 2015

Proteon initiates second phase III study of vonapanitase

Aug. 17, 2015

Daiichi Sankyo discloses compounds for hyperphosphatemia

Aug. 13, 2015

Relypsa signs new patiromer agreements

Aug. 12, 2015

FDA accepts NDA for ZS-9 in hyperkalemia

July 30, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...